World Hepatitis Alliance Activities
s
g
u
r
d
C
s
ti
ti
a
ep
h
ic
er
en
g
Shedding light on access to
MedsPaL database from the
Medicines Patents Pool
Knowledge for
Change Webinar
An Introduction to Access to Generic Hepatitis C Medicines
Information on the intellectual
property status of medicines is
often hard to find, making it difficult
to determine where generics are
available and the means by which
availability has been possible. To
fill the void of information, the
Medicines Patents Pool (MPP)
recently launched a new database
called MedsPaL (Medicines Patents
and Licenses Database) and for the
first time hepatitis C medicines are
now included alongside HIV and
tuberculosis drugs. The searchable
database provides information on
patents and licenses for generic
production across 101 low- and
middle-income countries.
Following the success of the first
two webinars in the Knowledge for
Change series covering access to
diagnostics and medicines, we were
pleased to deliver the next in the
series, ‘An Introduction to Accessing
Generic Hepatitis C Medicines’ on 1
November. Featuring experts Erika
Duenas, Advocacy Officer, Medicines
Patent Pool; Andrew Hill, Senior
Visiting Research Fellow, Department
of Pharmacology, University of
Liverpool; Giten Khwairakpam,
Project Manager for Community and
Policy, TREAT Asia; and Raquel Peck,
CEO, WHA, the webinar explored
the generics landscape for hepatitis
C with discussions on legalities,
quality and performance of generics
medicines as well as providing
examples of how people across the
globe are accessing them.
Explore the MedsPaL
database here
Missed our webinar?
Watch the recording here
6
hep
Voice October 2016
hep
Voice October 2016
7